CNP-104 improved key cholestasis endpoints at one year, including a composite serum alkaline phosphatase (ALP) and bilirubin biochemical ...

A woman diagnosed with a rare autoimmune liver disease says being laughed at after her skin turned yellow made living with the condition even more difficult. Lisa Woodcock, 42, was diagnosed with an ...

In patients with primary sclerosing cholangitis, biliary tract cancer is the leading cause of death. Yet very little is known about effective systemic treatments in these individuals. A new study ...

A primary biliary cholangitis (PBC) diagnosis can be life-changing. For many, it’s an emotional journey filled with questions, uncertainties and a need to redefine what life looks like with a chronic ...

Please provide your email address to receive an email when new articles are posted on . International Primary Biliary Cholangitis Day, celebrated on September 10, aspires to raise awareness of the ...

Primary Biliary Cholangitis (PBC) is an autoimmune disease where the small bile ducts of the liver become inflamed. The disease often goes undetected, potentially leading to scarring and cirrhosis of ...

Acute cholangitis is a severe, bacterial infection of the biliary tract precipitated by an obstruction that often results in systemic inflammation and, in some cases, life‐threatening sepsis. This ...

(RTTNews) - Primary Biliary Cholangitis is a rare, progressive, chronic autoimmune disease of the liver in which the small bile ducts are gradually destroyed, causing bile and other toxins to build up ...

Elafibranor, a dual peroxisome proliferator-activated receptor (PPAR) alpha and delta agonist, appears to be a safe and effective treatment of primary biliary cholangitis, according to a new clinical ...

Statin use in patients with primary biliary cholangitis is linked to lower risks for hepatic decompensation and major adverse liver outcomes.